Nuveen Asset Management’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$775K Hold
142,694
﹤0.01% 2816
2024
Q3
$1.03M Hold
142,694
﹤0.01% 2749
2024
Q2
$1.55M Hold
142,694
﹤0.01% 2507
2024
Q1
$2.67M Hold
142,694
﹤0.01% 2273
2023
Q4
$3.09M Buy
142,694
+1,319
+0.9% +$28.6K ﹤0.01% 2210
2023
Q3
$2.91M Sell
141,375
-172,074
-55% -$3.54M ﹤0.01% 2136
2023
Q2
$14.7M Buy
313,449
+173,664
+124% +$8.17M 0.01% 1269
2023
Q1
$5.87M Sell
139,785
-17,756
-11% -$745K ﹤0.01% 1800
2022
Q4
$6.01M Sell
157,541
-25,502
-14% -$973K ﹤0.01% 1812
2022
Q3
$7.17M Sell
183,043
-3,849
-2% -$151K ﹤0.01% 1686
2022
Q2
$6.04M Sell
186,892
-39,711
-18% -$1.28M ﹤0.01% 1820
2022
Q1
$7.61M Sell
226,603
-21,011
-8% -$706K ﹤0.01% 1814
2021
Q4
$10.5M Buy
247,614
+12,563
+5% +$534K ﹤0.01% 1653
2021
Q3
$10.4M Buy
235,051
+8,607
+4% +$381K ﹤0.01% 1750
2021
Q2
$12.9M Buy
226,444
+46,976
+26% +$2.67M ﹤0.01% 1695
2021
Q1
$13.4M Sell
179,468
-42,832
-19% -$3.21M ﹤0.01% 1611
2020
Q4
$19.2M Sell
222,300
-31,451
-12% -$2.72M 0.01% 1292
2020
Q3
$15.5M Sell
253,751
-26,684
-10% -$1.63M 0.01% 1219
2020
Q2
$11.7M Sell
280,435
-78,568
-22% -$3.27M ﹤0.01% 1381
2020
Q1
$10.3M Sell
359,003
-170,727
-32% -$4.9M 0.01% 1273
2019
Q4
$38.2M Buy
529,730
+57,482
+12% +$4.15M 0.01% 807
2019
Q3
$66.3M Sell
472,248
-149,177
-24% -$20.9M 0.03% 530
2019
Q2
$114M Buy
+621,425
New +$114M 0.04% 390
2018
Q3
Sell
-5,411
Closed -$847K 1062
2018
Q2
$847K Sell
5,411
-5,347
-50% -$837K 0.01% 766
2018
Q1
$1.73M Buy
10,758
+1,944
+22% +$313K 0.01% 639
2017
Q4
$1.45M Sell
8,814
-571
-6% -$94.1K 0.01% 663
2017
Q3
$585K Buy
9,385
+5,948
+173% +$371K ﹤0.01% 879
2017
Q2
$274K Buy
+3,437
New +$274K ﹤0.01% 1019
2016
Q2
Sell
-21,620
Closed -$693 1357
2016
Q1
$693 Buy
21,620
+1,327
+7% +$43 ﹤0.01% 1135
2015
Q4
$1.18K Sell
20,293
-656
-3% -$38 0.01% 974
2015
Q3
$886 Buy
+20,949
New +$886 0.01% 1099